Physician profile
Bo Lim
NPI 1861193328
$1,282.04
in general payments reported to CMS, 2019-2025
16 companies · $1,222 in 2025
The $1,222 reported for 2025 was more than what 86% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $59.57 · 2025: $1,222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,282.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $226.61 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $192.47 | 2024-2025 | Entyvio |
| Madrigal Pharmaceuticals | $150.46 | 2024-2025 | Rezdiffra, Resmetirom |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $116.13 | 2025 | Xifaxan |
| Ipsen Biopharmaceuticals, INC | $110.70 | 2025 | Iqirvo |
| Genzyme Corporation | $96.34 | 2025 | |
| Janssen Biotech, INC. | $79.14 | 2025 | Tremfya, Simponi Aria, Simponi |
| Regeneron Healthcare Solutions, INC. | $69.53 | 2025 | Dupixent |
| Phathom Pharmaceuticals, INC. | $67.43 | 2025 | Voquezna |
| Lilly USA, LLC | $56.74 | 2025 | Omvoh |
| Aimmune Therapeutics, INC. | $24.55 | 2025 | Zenpep |
| Novo Nordisk INC | $22.95 | 2025 | Wegovy |
| Celltrion USA INC. | $22.45 | 2025 | Vegzelma |
| Alnylam Pharmaceuticals INC. | $16.75 | 2025 | Oxlumo |
| Braintree Laboratories, INC. | $15.62 | 2024 | Suflave |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $14.17 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bo Lim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.